We and other groups have reported that CD133+ ovarian cancer cells both from cell lines and primary tumors showed CSC characteristics, including self-renewal, expression of stem cell markers, multi-differentiation and tumor initiation capacities, and therefore defined these CD133+ cells as ovarian cancer stem-like cells (CSLCs) [8, 13-14]. The gene discussed is PROM1; the disease is neoplasm.